# Exploring the impact of the innovative compound 3-(3-(4-hydroxy-2-oxo-2H-chromen-3-yl)-5-(pyridin-3-yl)-1H-pyrazol-1-yl) indolin-2-one on accelerating wound recovery

**Authors:** Ahmed Sabt, Heba Abdelmegeed, Abdel-Razik H. Abdel-Razik, Mohamed G. Thabit, Marwa Balaha, Moataz A. Shaldam, Ahmed M. Reda, Ahmed A. F. Soliman, Mohamed Abdelraof, Nehad A. Abdel Latif, Mai M. Elghonemy, Eman Y. Ahmed, Mohamed A. Abdelrahman, Rasha Z. Batran

PMC · DOI: 10.1038/s41598-026-37714-5 · Scientific Reports · 2026-02-21

## TL;DR

This study explores a new compound that accelerates wound healing and fights infection by enhancing cell migration and reducing inflammation.

## Contribution

The novel compound CPPI is shown to have antimicrobial and wound-healing properties through in vitro, in vivo, and in silico experiments.

## Key findings

- CPPI showed antimicrobial activity against MRSA, Bacillus cereus, and Pseudomonas aeruginosa.
- CPPI enhanced fibroblast migration and promoted wound healing in experimental models.
- Histological analysis showed reduced inflammation and complete re-epithelialization with CPPI treatment.

## Abstract

Wound healing represents a significant challenge within the field of medical science. Contemporary clinical practices increasingly favor the utilization of herbal compounds to facilitate the repair process. Among these compounds, coumarin-a phytochemical noted for its antibacterial and wound-healing properties-has garnered considerable attention. This study investigates the potential advantages of incorporating coumarin into wound dressings within an experimental model. Our synthesized target compound 3-(3-(4-hydroxy-2-oxo-2H-chromen-3-yl)-5-(pyridin-3-yl)-1H-pyrazol-1-yl) indolin-2-one (CPPI) demonstrated notable antimicrobial activity against the pathogenic Staphylococcus aureus MRSA, Bacillus cereus, and Pseudomonas aeruginosa. Moreover, both in vitro and in vivo experiments showed that CPPI significantly enhanced the migration of skin fibroblast cells and promoted the wound healing process. Furthermore, it facilitated complete re-epithelialization of the wounds. Histological analysis revealed the formation of well-structured granulation tissue and a reduction in indicators of wound infection, evidenced by a minimal presence of inflammatory cells in comparison to untreated wounds. Additionally, in silico molecular docking studies of CPPI indicated significant binding affinity within COX-2 active site along with a stable complex during molecular dynamics simulations. Collectively, the findings of this study suggest that CPPI can provide a protective effect against infections in cutaneous wounds, attributable to its antimicrobial properties.

The online version contains supplementary material available at 10.1038/s41598-026-37714-5.

## Linked entities

- **Proteins:** COX2 (cytochrome c oxidase subunit II)
- **Chemicals:** coumarin (PubChem CID 323)

## Full-text entities

- **Genes:** CTSC (cathepsin C) [NCBI Gene 1075] {aka CPPI, DPP-I, DPP1, DPPI, HMS, JP}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}
- **Diseases:** hemorrhage (MESH:D006470), fibrosis (MESH:D005355), Wound (MESH:D014947), inflammation (MESH:D007249), MD (MESH:D000092242), fungal (MESH:D009181), bruises (MESH:D003288), bacterial infections (MESH:D001424), Infections (MESH:D007239), wound infection (MESH:D014946), cytotoxicity (MESH:D064420)
- **Chemicals:** acetic acid (MESH:D019342), KBr (MESH:C039004), isatin (MESH:D007510), pyrazole (MESH:C031280), 13C (MESH:C000615229), Methicillin (MESH:D008712), ethanol (MESH:D000431), Kanamycin (MESH:D007612), water (MESH:D014867), Coumarin (MESH:C030123), Carbapenem (MESH:D015780), isoflurane (MESH:D007530), nitrogen (MESH:D009584), xylene (MESH:D014992), C (MESH:D002244), streptomycin (MESH:D013307), polymers (MESH:D011108), hydrazine hydrate (MESH:C029424), agar (MESH:D000362), ciprofloxacin (MESH:D002939), methanol (MESH:D000432), chalcone (MESH:D002599), silica gel (MESH:D058428), paraffin (MESH:D010232), O (MESH:D010100), acid (MESH:D000143), Hydrogen (MESH:D006859), Eosin (MESH:D004801), PBS (MESH:D007854), coumarins (MESH:D003374), indoline (MESH:C057812), formalin (MESH:D005557), Indole (MESH:C030374), DMSO (MESH:D004121), CO2 (MESH:D002245), L-glutamine (MESH:D005973), piperidine (MESH:C032727), Ampicillin (MESH:D000667), OH (MESH:C031356), iodine (MESH:D007455), chloroform (MESH:D002725), cephradine (MESH:D002515), indomethacin (MESH:D007213), cephalosporin (MESH:D002511), sulfur (MESH:D013455), melatonin (MESH:D008550), H &amp;E (MESH:D006371), CH-pyrazole (-), penicillin (MESH:D010406), Na (MESH:D012964), Haematoxylin (MESH:D006416), phosphorus oxychloride (MESH:C013196), potassium (MESH:D011188), 4-hydroxycoumarin (MESH:C068805), Pyridine (MESH:C023666)
- **Species:** Pseudomonas aeruginosa (species) [taxon 287], Aspergillus niger (species) [taxon 5061], Candida albicans (species) [taxon 5476], Bacillus cereus (species) [taxon 1396], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Nymphoides peltata (species) [taxon 49614], Rattus norvegicus (brown rat, species) [taxon 10116], Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** V600E
- **Cell lines:** BJ — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_6573)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12929582/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12929582/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12929582/full.md

---
Source: https://tomesphere.com/paper/PMC12929582